companydata.dkOptoceutics ApS: Financial statements 2022
CVR: 39769689
Optoceutics ApS (CVR 39769689) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 4,262,725 and a net result of DKK -3,635,660 compared with DKK -3,880,378 the year before. Equity amounted to DKK 16,943,109. The solvency ratio was 56.6%. The company had 14 employees in the financial year.
- Gross Profit
- 4,262,725 kr.
- Profit/Loss
- -3,635,660 kr.
- Equity
- 16,943,109 kr.
- Total Assets
- 29,925,919 kr.
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 4.3 mio. | -3.6 mio. | 16.9 mio. | 14 |
| 2021 | - | -2.2 mio. | -3.9 mio. | 13.4 mio. | 10 |
| 2020 | - | -132 t. | -506 t. | 16.2 mio. | 6 |
Keep an eye on Optoceutics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of November 7, 2022, Danielsen 2 ApS is registered as an owner of Optoceutics ApS with an ownership share of 25%.
As of November 7, 2022, is registered as an owner of Optoceutics ApS with an ownership share of 15%.
Optoceutics ApS has published its annual report for 2021. Gross profit came to DKK -2,177,118, and the net result was DKK -3,880,378.
About Optoceutics ApS
Optoceutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Optoceutics IVS. The management consists of Marcus Schultz Carstensen and Ngoc Mai Thi Nguyen. The company's owners include Vjack Holding ApS, M. S. C. HOLDING ApS and Danielsen 2 ApS. In 2025, the company reported a gross profit of DKK -2,585,556 and a net result of DKK -8,736,152 compared with DKK -9,184,625 the year before. Equity amounted to DKK 32,320,160.